Answer
Concomitant use should be avoided because letermovir induces enzymes and transporters, potentially reducing dabigatran plasma concentrations and efficacy.
Sources for this answer
- PREVYMIS 240 mg film-coated tabletsMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 14Document updated
Sources checked